Table 1.

Baseline characteristics

Characteristics	n = 44 eyes of 42 patients
Age (years)	52.50 ± 8.14
Gender (male/female)	2.1:1
RT-PCR COVID-19 test positive	20
Diabetes mellitus	30
Oxygen treatment given during COVID-19 infection	22
Steroid treatment given during COVID-19 infection	21
HbA1c (mean)	12.56%
D-Dimer (mean)	2.17ug/ml
Serum ferritin (mean)	834 ng/ml
ROCM staging
3A	0
3B	22
3C	12
3D	2
4A	3
4B	2
4C	1
4D	0

HbA1c Glycated haemoglobin, ROCM Rhino-orbital-cerebral-mucormycosis,

ROCM staging 3A—Nasolacrimal duct, medial orbit, vision unaffected, 3B—Diffuse orbital involvement (> 1 quadrant), vision unaffected, 3C—central retinal artery or ophthalmic artery occlusion or superior ophthalmic vein thrombosis; involvement of superior/inferior orbital fissure, orbital apex, loss of vision, 3D—bilateral orbital involvement, 4A—Focal or partial cavernous sinus or cribriform plate involvement, 4B—diffuse cavernous sinus involvement or thrombosis, 4C—involvement beyond cavernous sinus, skull base, internal carotid artery occlusion, brain infarction, 4D—multifocal or diffuse CNS disease